Human papillomavirus E6 protein enriches the CD55(+) population in cervical cancer cells, promoting radioresistance and cancer aggressiveness

Publisher： John Wiley & Sons Inc

E-ISSN： 1555-2039|244|2|151-163

ISSN： 0022-3417

Source： THE JOURNAL OF PATHOLOGY, Vol.244, Iss.2, 2018-02, pp. : 151-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of radioresistance in drug resistant human MCF-7 breast cancer cells

By  

Journal of Radiotherapy in Practice, Vol. 8, Iss. 4, 2009-12 ,pp. : 207-213

Cambridge University Press

Access to resources Recommend Favorite

Human papillomavirus vaccination and screening as the new paradigm in cervical cancer prevention

By Franco Eduardo L   Paavonen Jorma  

Therapy, Vol. 5, Iss. 3, 2008-05 ,pp. : 261-263

Future Medicine

Access to resources Recommend Favorite

Human Papillomavirus 16 E6/E7 Transcript and E2 Gene Status in Patients with Cervical Neoplasia

By Sathish N.  

Molecular Diagnosis, Vol. 8, Iss. 1, 2004-01 ,pp. : 57-64

Adis International

Access to resources Recommend Favorite

Analyses of Bcl-2, Survivin, and CD44v6 expressions and human papillomavirus infection in cervical carcinomas

By Yaqin M.   Runhua L.   Fuxi Z.  

Scandinavian Journal of Infectious Diseases, Vol. 39, Iss. 5, 2007-01 ,pp. : 441-448

Informa Healthcare

Access to resources Recommend Favorite

Association of epidermal growth factor receptor mutations with human papillomavirus 16/18 E6 oncoprotein expression in non–small cell lung cancer

By  

CANCER, Vol. 119, Iss. 18, 2013-09 ,pp. : 3367-3376

John Wiley & Sons Inc

Access to resources Recommend Favorite